Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.

Gertig DM, Brotherton JM, Saville M.

Sex Health. 2011 Jun;8(2):171-8. doi: 10.1071/SH10001. Review.

PMID:
21592430
2.

Post-licensure monitoring of HPV vaccine in the United States.

Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF.

Vaccine. 2010 Jul 5;28(30):4731-7. doi: 10.1016/j.vaccine.2010.02.019. Epub 2010 Feb 25. Review.

PMID:
20188681
3.

Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.

Ault K, Reisinger K.

Int J Infect Dis. 2007 Nov;11 Suppl 2:S26-8. doi: 10.1016/S1201-9712(07)60018-6. Review.

4.

[Diseases caused by human papilloma viruses].

Zollner U, Schwarz TF.

Dtsch Med Wochenschr. 2011 May;136(20):1067-72. doi: 10.1055/s-0031-1275845. Epub 2011 May 10. Review. German.

PMID:
21560109
5.

What can surveillance of genital warts tell us?

Fairley CK, Donovan B.

Sex Health. 2010 Sep;7(3):325-7. doi: 10.1071/SH09145. Review.

PMID:
20719222
6.

Start early to prevent genital HPV infection-and cervical cancer.

Heavey E.

Nursing. 2008 May;38(5):62-3. doi: 10.1097/01.NURSE.0000317694.60224.38. Review. No abstract available.

PMID:
18431214
7.

Using the new HPV vaccines in clinical practice.

Widdice LE, Kahn JA.

Cleve Clin J Med. 2006 Oct;73(10):929-35. Review.

PMID:
17044318
8.

The Australian experience with the human papillomavirus vaccine.

Garland SM.

Clin Ther. 2014 Jan 1;36(1):17-23. doi: 10.1016/j.clinthera.2013.12.005. Review.

PMID:
24417782
9.

Prevention strategies against the human papillomavirus: the effectiveness of vaccination.

Stanley M.

Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S19-23. Review.

PMID:
17938013
10.

Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries.

Wong CA, Saraiya M, Hariri S, Eckert L, Howlett RI, Markowitz LE, Brotherton JM, Sinka K, Martinez-Montañez OG, Kjaer SK, Dunne EF.

Vaccine. 2011 Jan 29;29(5):878-85. doi: 10.1016/j.vaccine.2010.10.018. Epub 2010 Nov 5. Review.

PMID:
20971113
11.

[Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline].

Gross G, Gissmann L, Hillemanns P, Ikenberg H, Kaufmann AM, Petry KU, Pfister H, Schneede P, Schneider A, Smola S; für das HPV-Management Forum.

Dtsch Med Wochenschr. 2010 May;135(21):1083-6. doi: 10.1055/s-0030-1253704. Epub 2010 May 19. German. No abstract available.

PMID:
20486060
12.

Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines.

Hildesheim A, Markowitz L, Avila MH, Franceschi S.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/227-32. Epub 2006 Jun 19. Review.

PMID:
16950011
13.
14.

The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.

Thomas TL.

Pediatr Nurs. 2008 Sep-Oct;34(5):429-31. Review.

PMID:
19051848
15.

Human papillomavirus vaccine introduction--the first five years.

Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JM.

Vaccine. 2012 Nov 20;30 Suppl 5:F139-48. doi: 10.1016/j.vaccine.2012.05.039. Review. Erratum in: Vaccine. 2014 Feb 26;32(10):1225.

PMID:
23199957
16.

Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States.

Grant LA, Dunne EF, Chesson H, Markowitz LE.

Vaccine. 2011 Mar 16;29(13):2365-70. doi: 10.1016/j.vaccine.2011.01.032. Epub 2011 Jan 28. Review.

PMID:
21277406
17.

HPV vaccine update: new indications and controversies.

Mendoza N, Hernandez PO, Tyring SK.

Skin Therapy Lett. 2011 Sep;16(8):1-3. Review.

18.

A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.

Dunne EF, Datta SD, E Markowitz L.

Cancer. 2008 Nov 15;113(10 Suppl):2995-3003. doi: 10.1002/cncr.23763. Review.

19.

The prophylactic role for the human papillomavirus quadrivalent vaccine in males.

Yancey AM, Pitlick JM, Forinash AB.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1314-8. doi: 10.1345/aph.1P017. Epub 2010 May 25. Review.

PMID:
20501891
20.

Adolescent and young adult HPV vaccination in Australia: achievements and challenges.

Garland SM, Skinner SR, Brotherton JM.

Prev Med. 2011 Oct;53 Suppl 1:S29-35. doi: 10.1016/j.ypmed.2011.08.015. Review.

PMID:
21962468

Supplemental Content

Support Center